Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Head and Neck Neoplasms Clinical Trial

Official title:

Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00180180
• Other study ID #: HNO-FMISO-FU
• Status: Completed
• Start date: July 2006
• Est. completion date: October 2018

Study information

• Verified date: February 2020
• Source: Technische Universität Dresden
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: October 2018
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• histologically confirmed head-and-neck cancer not curable by surgery

• Karnofsky > 70%

• tumor volume and localisation allow curative radiotherapy

• written consent

Exclusion Criteria:

• metastases

• earlier radiation therapy of head and neck

• pregnancy

• secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri

• psychiatric impairment

Related Conditions & MeSH terms

• Head and Neck Neoplasms
• Hypoxia

Locations

Country	Name	City	State
Germany	Department of Nuclear Medicine	Dresden

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany,